Provided by Tiger Trade Technology Pte. Ltd.

Immix Biopharma, Inc.

6.84
+0.11001.63%
Post-market: 6.80-0.0400-0.58%19:31 EST
Volume:1.25M
Turnover:8.53M
Market Cap:362.21M
PE:-8.80
High:6.97
Open:6.73
Low:6.56
Close:6.73
52wk High:7.73
52wk Low:1.34
Shares:52.96M
Float Shares:41.44M
Volume Ratio:1.32
T/O Rate:3.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.7641
ROE:-182.55%
ROA:-66.48%
PB:43.83
PE(LYR):-8.95

Loading ...

Immix Biopharma Inc : Mizuho Initiates Coverage With Outperform Rating; Price Target $14

THOMSON REUTERS
·
Feb 09

Immix Biopharma Inc. unveils new presentation on relapsed/refractory AL amyloidosis treatment challenges

Reuters
·
Feb 05

BUZZ-Immix climbs on FDA's 'breakthrough' tag for blood disorder therapy

Reuters
·
Jan 28

FDA Grants Breakthrough Therapy Designation to Immix Biopharma's NXC-201 for AL Amyloidosis

Reuters
·
Jan 28

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for Nxc-201

THOMSON REUTERS
·
Jan 28

Immix Biopharma Inc: Final Data Expected This Year Followed by Planned Bla Submission

THOMSON REUTERS
·
Jan 28

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities

Benzinga_recent_news
·
Jan 12

BRIEF-Immix Biopharma To Offer And Sell Up To $750 Million In Securities - SEC Filing

Reuters
·
Jan 10

Immix Biopharma files $750M mixed securities shelf

TIPRANKS
·
Jan 10

Immix Biopharma Inc - to Offer and Sell up to $750 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Jan 10

Immix Biopharma Inc. unveils presentation on relapsed/refractory AL amyloidosis treatment challenges

Reuters
·
Jan 10

Immix Biopharma CEO Ilya Rachman Acquires Common Shares

Reuters
·
Dec 11, 2025

Immix Biopharma CFO Gabriel S. Morris Reports Acquisition of Common Shares

Reuters
·
Dec 11, 2025

BRIEF-Immix Biopharma Announces Closing Of Upsized $100 Million Underwritten Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
Dec 10, 2025

Immix Biopharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 09, 2025

Immix Biopharma, Inc. : H.c. Wainwright Raises Target Price to $12 From $8

THOMSON REUTERS
·
Dec 09, 2025

Immix Biopharma Inc. unveils presentation on relapsed/refractory AL amyloidosis treatment challenges

Reuters
·
Dec 09, 2025

BRIEF-Immix Biopharma Prices Offering Of 19.1 Million Shares At $5.10 Per Share

Reuters
·
Dec 08, 2025

Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Dec 08, 2025

Immix Biopharma Inc - Prices Offering of 19.12 Mln Shares at $5.10 per Share

THOMSON REUTERS
·
Dec 08, 2025